肺癌手术治疗中可必特联合沐舒坦术前雾化吸入的效果分析

陆振刚

（甘肃省定西市人民医院胸外科，甘肃 定西，743000）

浏览次数：168次 下载次数：460次

摘要：

目的 观察并讨论肺癌手术治疗中可必特联合沐舒坦术前雾化吸入的临床疗效。方法 选取2013 年12 月至2016 年12月本院90 例肺癌患者，将其随机分成研究组与对照组，各45 例。对照组术前接受常规生理盐水联合沐舒坦雾化吸入治疗， 研究组术前接受可必特联合沐舒坦雾化吸入治疗。观察两组治疗后的术后动脉血气、肺功能、围手术期并发症发生率及细胞计数。结果 术后，两组患者的PaCO2、PaO2、SaO2、MVV、FEV1 水平比较，差异具有统计学意义（P<0.05）；研究组围手术期并发症总发生率明显低于对照组，差异具有统计学意义（P<0.05）；两组白细胞计数、中性粒细胞、中性粒细胞绝对值比较，差异具有统计学意义（P<0.05）。结论 肺癌患者术前应用可必特联合沐舒坦术前雾化吸入的临床疗效显著，值得临床推广。

关键词：肺癌手术；可必特；沐舒坦；雾化吸入

中图分类号：R734.2文献标志码：A文章编号：2096-1413(2018)03-0050-02

Effect analysis of combivent combined with mucosolvan preoperative inhalationin in lung cancer surgery
LU Zhen-gang
(Thoracic Surgery Department, the People``s Hospital of Dingxi, Dingxi 734000, China)

ABSTRACT: Objective To observe and discuss the clinical curative effect of combivent combined with mucosolvan preoperative inhalationin in lung cancer surgery. Methods A total of 90 lung cancer patients underwent lung cancer surgery in our hospital from December 2013 to December 2016 were randomly divided into study group and control group, with 45 cases in each group. The control group received conventional saline combined with mucosolvan inhalation before surgery. The study group received combivent combined with mucosolvan preoperative inhalation. The postoperative arterial blood gas, lung function, perioperative complications and cell count were observed in the two groups after treatment. Results The levels of PaCO2, PaO2, SaO2, MVV and FEV1 in the two groups had significant differences (P<0.05); the incidence of perioperative complications in the study group was significantly less than that in the control group (P<0.05); the white blood cell count, neutrophil and neutrophil absolute value in the two groups had significant differences (P<0.05). Conclusion Combivent combined with mucosolvan preoperative inhalation in patients with lung cancer surgery has significant curative effect, which is worthy of promotion.
KEYWORDS: lung cancer; combivent; mucosolvan; inhalation

参考文献：
[1] 姜春萍.干扰素α1b 联合普米克及可必特雾化吸入在毛细支气管炎中的疗效观察[J].中国医药指南,2017,15(2):78-79.
[2] 周虹,付国斌,张文.酪氨酸激酶抑制剂的药物相互作用研究进展[J].中国新药与临床杂志,2016,35(12):854-860.
[3] 刘枚,饶长秀,曾苏华.可必特联合沐舒坦术前雾化吸入在肺癌手术治疗中的应用效果[J].实用临床医学,2014,15(10):53-54.
[4] 李晓红,曹琳.中医护理在分子靶向药物治疗肺癌致皮肤不良反应中的应用观察[J].贵州医药,2017,41(1):105-106.
[5] 李国扬.原发性肺癌患者血清ADH、TNF-琢 水平与其预后关系研究[J].白求恩医学杂志,2015,13(4):341-342.
[6] 贾友超,焦顺昌.微小RNA 在肺癌精确诊断及靶向治疗中的应用[J].白求恩医学杂志,2016,14(1):84-87.
[7] 曹强,杨杨,郭建峰,等.VATS 与开胸手术治疗高龄早期非小细胞肺癌术后心律失常类型及发生率比较[J].白求恩医学杂志,2015,13(3):291-292.
[8] LIM J,LITTON E,ROBINSON H,et al.Characteristics and outcomes of patients treated with airway pressure release ventilation for acute respiratory distress syndrome: a retrospective observational study[J].J Crit Care,2016,31(34):154-159.